Delivery Order SPE2DB20D3103-SPE2DB24FL8F6
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ketorolac 30 mg/ml vial. The contract has a firm fixed price, is not set aside, and has a ceiling value of $4,102.92. The ultimate completion date is October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,609.74, is for the delivery of the drug Ketorolac 30 mg/ml in vials. It is a Firm Fixed Price contract that runs through January 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $4,797.29 firm-fixed-price contract is for the delivery of Ketorolac 30 mg/ml vials, a pain medication. It does not have a set-aside designation. The delivery order was awarded on August 15, 2024, with a completion date of August 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $2,018.90 fixed-price contract is for the supply of Ketorolac 30 mg/mL vial, a pharmaceutical product used to treat moderate to severe pain. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. This order does not utilize a set-aside. AmerisourceBergen is a major pharmaceutical distributor that has been...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management pharmaceutical, with a ceiling value of $5,208.03 and a performance period through June 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the corporate office division of Amerisourcebergen Corporation. The $1,124.88 firm fixed price contract is for the supply of 4564324620 KETOROLAC 30 MG/ML VIALML, a pharmaceutical product. The contract has an ultimate completion date of April 19, 2024 and was awarded on April 18, 2024 without a set-aside designation. Amerisourcebergen, a major...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ketorolac 30mg/ml 25s, a pain medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,029.16, is a firm fixed-price delivery order contract with a completion date of December 12, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.40 firm fixed-price delivery order is for the supply of 4566728770 - Ketorolac 30 mg/ml vial, a pain management medication. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KETOROLAC 15 MG/ML VIALML, a pain management pharmaceutical product, with a ceiling value of $1,637.00 and a period of performance ending on June 13, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corporation holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,454.70, is a delivery order for the supply of ketorolac 30 mg/ml vials. The contract has an ultimate completion date of December 24, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FL8F6Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,378.40 firm-fixed-price contract is for the delivery of Ketorolac 30 mg/ml vials, a pain management medication. The contract has an ultimate completion date of December 8, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is likely part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 12/7/23 |